[Modern aspects of diabetic ketoacidosis treatment in children]

Insights

This study presents a novel treatment for diabetic ketoacidosis in children with type 1 diabetes, utilizing glucose solutions and small insulin doses to safely manage blood glucose and pH levels, preventing complications like cerebral edema.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Biophysics

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes mellitus (T1DM) in children.
  • Effective management of DKA is crucial to prevent life-threatening complications such as cerebral edema.
  • Understanding the physiological dynamics of DKA is essential for optimizing treatment strategies.

Purpose of the Study:

  • To analyze the regularities of DKA treatment in pediatric patients with T1DM.
  • To explain DKA treatment outcomes using principles from biological systems stability theory.
  • To evaluate a novel therapeutic approach for DKA in children.

Main Methods:

  • The study included 90 pediatric patients diagnosed with T1DM and DKA of varying severity.
  • Blood glucose and acid-base status indicators (including pH) were measured using a GEM Premier 3000 gas analyzer.
  • Patients were treated according to a protocol involving glucose solutions and low-dose insulin infusion.

Main Results:

  • All 90 children were successfully treated for DKA without complications.
  • The treatment protocol, involving glucose solutions and small insulin doses despite hyperglycemia, effectively prevented cerebral edema.
  • pH recovery was observed and explained through the lens of biological systems stability theory, identifying three stationary states (pH 7.4, pH < 6.9) and an unstable state (pH 6.9).

Conclusions:

  • The proposed DKA treatment method, incorporating glucose solutions and small insulin doses, effectively normalizes pH and glucose levels.
  • This approach ensures patient safety, even in high-risk individuals prone to cerebral edema.
  • Biological systems stability theory supports the efficacy of this innovative DKA management strategy.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...